This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
WHO:Public Health Imperative, E-book ed. 2019;1. Available from: https://apps.who.int/iris/rest/bitstreams/1235662/retrieveWHOPublic Health Imperative, E-book ed20191Available from: https://apps.who.int/iris/rest/bitstreams/1235662/retrieveSearch in Google Scholar
WHO:Atlas: Country resources for neurological disorders. 2017, 175–178 p. Available from: https://apps.who.int/iris/rest/bit-streams/1088639/retrieveWHOAtlas: Country resources for neurological disorders2017175178Available from: https://apps.who.int/iris/rest/bit-streams/1088639/retrieveSearch in Google Scholar
Campbell M., McKenzie J.E., Sowden A., Katikireddi S.V., Brennan S.E., Ellis S. et al.:Synthesis without meta-analysis (SWiM) in systematic reviews: Reporting guideline. BMJ, 2020, 368: 1–6. doi: 10.1136/bmj.l6890.CampbellM.McKenzieJ.E.SowdenA.KatikireddiS.V.BrennanS.E.EllisS.Synthesis without meta-analysis (SWiM) in systematic reviews: Reporting guidelineBMJ20203681610.1136/bmj.l6890Open DOISearch in Google Scholar
Costa T., Fernandez-Villalba E., Izura V., Lucas-Ochoa A., Menezes-Filho N., Santana R. et al.:Combined 1-Deoxynojirimycin and Ibuprofen Treatment Decreases Microglial Activation, Phagocytosis and Dopaminergic Degeneration in MPTP-Treated Mice. J. Neuroimmune Pharmacol., 2021, 16: 390–402. doi: 10.1007/s11481-020-09925-8CostaT.Fernandez-VillalbaE.IzuraV.Lucas-OchoaA.Menezes-FilhoN.SantanaR.Combined 1-Deoxynojirimycin and Ibuprofen Treatment Decreases Microglial Activation, Phagocytosis and Dopaminergic Degeneration in MPTP-Treated MiceJ. Neuroimmune Pharmacol.20211639040210.1007/s11481-020-09925-8Open DOISearch in Google Scholar
Durankuş F., Şenkal E., Sünnetçi E., Albayrak Y., Beyazyüz M., Atasoy Ö. et al.:Beneficial Effects of Ibuprofen on Pentylenetetrazol-induced Convulsion. Neurochem. Res., 2020, 45: 2409–2416. doi: 10.1007/s11064-020-03101-3DurankuşF.ŞenkalE.SünnetçiE.AlbayrakY.BeyazyüzM.AtasoyÖ.Beneficial Effects of Ibuprofen on Pentylenetetrazol-induced ConvulsionNeurochem. Res.2020452409241610.1007/s11064-020-03101-3Open DOISearch in Google Scholar
Goodman L.S., Gilman A. In:Goodman & Gillman’s The Pharmacological Basis of Therapeutics. E-book 13th ed. Brunton L.L., Hilal-Dandan R., Knollmann B.C. (eds.) McGraw-Hill Education, 2018.GoodmanL.S.GilmanA.Goodman & Gillman’s The Pharmacological Basis of TherapeuticsE-book13th edBruntonL.L.Hilal-DandanR.KnollmannB.C.(eds.)McGraw-Hill Education2018Search in Google Scholar
Hooijmans C.R, Rovers M.M., De Vries R.B.M., Leenaars M., Ritskes-Hoitinga M., Langendam M.W.:SYRCLE’s risk of bias tool for animal studies. BMC Med. Res. Methodol., 2014, 14: 1–9. doi: 10.1186/1471-2288-14-43HooijmansC.RRoversM.M.De VriesR.B.M.LeenaarsM.Ritskes-HoitingaM.LangendamM.W.SYRCLE’s risk of bias tool for animal studiesBMC Med. Res. Methodol.2014141910.1186/1471-2288-14-43Open DOISearch in Google Scholar
Khansari P.S., Coyne L.:NSAIDs in the treatment and/or prevention of neurological disorders. Inflammopharmacology Jun., 2012 p. 159–167. doi: 10.1007/s10787-011-0116-2KhansariP.S.CoyneL.NSAIDs in the treatment and/or prevention of neurological disordersInflammopharmacology Jun.201215916710.1007/s10787-011-0116-2Open DOISearch in Google Scholar
Liu R., Wu S., Guo C., Hu Z., Peng J., Guo K. et al.:Ibuprofen Exerts Antiepileptic and Neuroprotective Effects in the Rat Model of Pentylenetetrazol-Induced Epilepsy via the COX-2/NLRP3/IL-18 Pathway. Neurochem. Res., 2020, 45: 2516–2256. doi: 10.1007/s11064-020-03109-9LiuR.WuS.GuoC.HuZ.PengJ.GuoK.Ibuprofen Exerts Antiepileptic and Neuroprotective Effects in the Rat Model of Pentylenetetrazol-Induced Epilepsy via the COX-2/NLRP3/IL-18 PathwayNeurochem. Res.2020452516225610.1007/s11064-020-03109-9Open DOISearch in Google Scholar
Page M.J,. McKenzie J.E., Bossuyt P.M., Boutron I., Hoffmann T.C., Mulrow C.D. et al.:The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ, 2021, 372. doi: 10.1136/bmj.n71PageM.J.McKenzieJ.E.BossuytP.M.BoutronI.HoffmannT.C.MulrowC.D.The PRISMA 2020 statement: An updated guideline for reporting systematic reviewsBMJ202137210.1136/bmj.n71Open DOISearch in Google Scholar
Peng J., Wu S., Guo C., Guo K., Zhang W., Liu R. et al.:Effect of Ibuprofen on Autophagy of Astrocytes During Pentylenetetrazol-Induced Epilepsy and its Significance: An Experimental Study. Neurochem. Res., 2019, 44: 2566–2576. doi: 10.1007/s11064-019-02875-5PengJ.WuS.GuoC.GuoK.ZhangW.LiuR.Effect of Ibuprofen on Autophagy of Astrocytes During Pentylenetetrazol-Induced Epilepsy and its Significance: An Experimental StudyNeurochem. Res.2019442566257610.1007/s11064-019-02875-5Open DOISearch in Google Scholar
Rawat C., Kukal S., Dahiya U.R., Kukreti R.:Cyclooxygenase-2 (COX-2) inhibitors: future therapeutic strategies for epilepsy management. J. Neuroinflammation, 2019, 16: 197. doi: /10.1186/s12974-019-1592-3.RawatC.KukalS.DahiyaU.R.KukretiR.Cyclooxygenase-2 (COX-2) inhibitors: future therapeutic strategies for epilepsy managementJ. Neuroinflammation20191619710.1186/s12974-019-1592-3Open DOISearch in Google Scholar
Roberts M.K., Chaney S.:Heparin-induced Thrombocytopenia. J. Nurse Pract., 2018, 14: 402–408.e3. doi: 10.1016/j.nurpra.2018.02.007RobertsM.K.ChaneyS.Heparin-induced ThrombocytopeniaJ. Nurse Pract.201814402408.e310.1016/j.nurpra.2018.02.007Open DOISearch in Google Scholar
Vezzani A., Balosso S,. Ravizza T. :Neuroinflammatory pathways as treatment targets and biomarkers in epilepsy. Nat. Rev. Neurol., 2019, 15: 459–472. doi: 10.1038/s41582-019-0217-xVezzaniA.BalossoS.RavizzaT.Neuroinflammatory pathways as treatment targets and biomarkers in epilepsyNat. Rev. Neurol.20191545947210.1038/s41582-019-0217-xOpen DOISearch in Google Scholar
Zhang C., Qin H., Zheng R., Wang Y., Yan T., Huan F. et al.:A new approach for Alzheimer’s disease treatment through P-gp regulation via ibuprofen. Pathol. Res. Pract., 2018, 214: 1765–1771. doi: 10.1016/j.prp.2018.08.011ZhangC.QinH.ZhengR.WangY.YanT.HuanF.A new approach for Alzheimer’s disease treatment through P-gp regulation via ibuprofenPathol. Res. Pract.20182141765177110.1016/j.prp.2018.08.011Open DOISearch in Google Scholar